Ditte M. Karpf

A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models

Henning R. Stennicke, Marianne Kjalke, Ditte M. Karpf et al. · Blood · 2013 · 115 citations · Full text

Medicine, Hematology, Pharmacology +2

Clinical studies with oral lipid based formulations of poorly soluble compounds.

Dimitrios G. Fatouros, Ditte M. Karpf, F. S. Nielsen et al. · PubMed · 2007 · 94 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice

Torben Elm, Ditte M. Karpf, K. ØVLISEN et al. · Haemophilia · 2011 · 35 citations

Medicine, Pharmacokinetics, Pharmacology +12

Influence of the Type of Surfactant and the Degree of Dispersion on the Lymphatic Transport of Halofantrine in Conscious Rats

Ditte M. Karpf, René Holm, Henning Gjelstrup Kristensen et al. · Pharmaceutical Research · 2004 · 29 citations

Engineering, Pharmacokinetics, Physiology +13

Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors

Torben Elm, Mirella Ezban, Thomas N. Krogh et al. · Thrombosis and Haemostasis · 2009 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +16